Opens in a new tab

Playbook

Marketing Applications Break Down in Execution. Not Science.

Preparing a marketing application requires coordination across clinical, regulatory, and writing teams, often under tight timelines.

This playbook outlines how to structure the process more effectively and avoid common points of delay.

Download the Playbook
Healthcare professionals reviewing clinical development plan and risk assessment charts, discussing dosage forms and stability planning using tablet and printed reports.

What you’ll learn

Four key areas this playbook covers

How to structure marketing applications across teams and functions

Where submissions typically lose time and create risk

How to improve coordination, ownership, and review cycles

What experienced teams do differently to keep work moving

Access the playbook

Developed by teams experienced in NDA, BLA, and MAA submissions.

Regulatory affairs professional reviewing clinical trial results and FDA submission data on a large analytics dashboard displaying efficacy, safety outcomes, and statistical analysis.

Why this matters

We are champions of science.

Strong science does not guarantee a strong submission.

Many delays occur because of how the work is structured across teams, not because of gaps in the underlying data.

Marketing applications require alignment across clinical, regulatory, and medical writing functions, often under compressed timelines and evolving inputs.

Without a clear structure for planning, ownership, and review, even well-prepared teams can lose time and introduce unnecessary complexity.

This playbook focuses on how to approach the process more deliberately so submissions move forward with greater clarity and control.

Process Insight

Where teams run into challenges

1

Unclear ownership across functional groups

2

Inefficient or reactive review cycles

3

Misalignment between contributors

4

Late-stage rework that impacts timelines

Who this is for

Supply chain analyst monitors global shipment routes on digital maps to help protect clinical trial supply chains from geopolitical risk and disruptions.

Regulatory affairs leaders preparing marketing applications

Lab analyst in a white coat, gloves, and safety glasses reviews HPLC chromatography data on a computer and records results in a notebook in a GMP lab.

Clinical and development teams supporting submissions

Scientist analyzing assay results and stability study data on dual monitors while holding sample vials in a laboratory setting.

Medical writing teams managing complex documentation

biopharma leadership team reviewing regulatory timelines and market strategy data during corporate meeting

Sponsors coordinating cross-functional submission efforts

A more structured approach leads to a more predictable submission process

Download the Playbook